All patients treated for brain tumor are eligible for participation in this study (does not have to be enrolled on a COG therapeutic study)
Brain tumor biological specimens, derived from primary tumors of the central nervous system must be available for submission for tumor banking
Patients are eligible at the time of diagnosis of their primary neoplasm, at the time of second look surgery, at recurrence, or at the development of a second malignant neoplasm